Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

819

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

April 30, 2008

Study Completion Date

January 31, 2016

Conditions
Prostate Cancer
Interventions
DRUG

bicalutamide

DRUG

goserelin acetate

PROCEDURE

adjuvant therapy

RADIATION

radiation therapy

Trial Locations (20)

6

Saint Luke's Hospital, Dublin

1090

Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels

1200

Cliniques Universitaires Saint-Luc, Brussels

16132

Istituto Nazionale per la Ricerca sul Cancro, Genoa

21079

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon

25030

Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besançon

25124

Spedali Civili di Brescia, Brescia

38043

CHU de Grenoble - Hopital de la Tronche, Grenoble

56001

Centre d'Oncologie Saint-Yves, Vannes

67085

Centre Paul Strauss, Strasbourg

B-3000

U.Z. Gasthuisberg, Leuven

2006 Strovolos

Bank Of Cyprus Oncology Centre, Nicosia

500 05

Charles University Hospital, Hradec Králové

L-4240

Hopital de la Ville D'Esch-sur-Alzette, Esch-sur-Alzette

6815 AD

Arnhems Radiotherapeutisch Instituut, Arnhem

9700 RB

University Medical Center Groningen, Groningen

5042 SB

Dr. Bernard Verbeeten Instituut, Tilburg

80-211

Medical University of Gdansk, Gdansk

08907

Institut Catala d'Oncologia - Hospital Duran i Reynals, Barcelona

BT8 8JR

Belfast City Hospital Trust Incorporating Belvoir Park Hospital, Belfast

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00021450 - Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter